Copyright
©The Author(s) 2016.
World J Clin Oncol. Oct 10, 2016; 7(5): 387-394
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.387
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.387
Population of lymphocytes | n | Pre-NAC Me ± IQR | Post-NAC Me ± IQR | P-value2 | P corrected value3 |
Percentage | |||||
H and E whole slide | 73 | 40 ± 15 | 20 ± 15 | < 0.001 | < 0.0021 |
H and E TMA | 16 | 30 ± 17.5 | 15 ± 15 | 0.4321 | |
Absolute counting | |||||
CD3 | 22 | 244.5 ± 315.5 | 255.5 ± 267 | 0.8583 | |
CD4 | 7 | 14 ± 94 | 32 ± 43 | 0.6721 | |
CD8 | 21 | 127 ± 193.5 | 156 ± 90.5 | 0.7544 | |
FOXP3 | 21 | 18 ± 31 | 12 ± 19.5 | 0.0917 |
- Citation: Castaneda CA, Mittendorf E, Casavilca S, Wu Y, Castillo M, Arboleda P, Nunez T, Guerra H, Barrionuevo C, Dolores-Cerna K, Belmar-Lopez C, Abugattas J, Calderon G, De La Cruz M, Cotrina M, Dunstan J, Gomez HL, Vidaurre T. Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy. World J Clin Oncol 2016; 7(5): 387-394
- URL: https://www.wjgnet.com/2218-4333/full/v7/i5/387.htm
- DOI: https://dx.doi.org/10.5306/wjco.v7.i5.387